427 related articles for article (PubMed ID: 19088796)
21. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.
de Vries TJ; Kitson JL; Silvers WK; Mintz B
Cancer Res; 1995 Oct; 55(20):4681-7. PubMed ID: 7553649
[TBL] [Abstract][Full Text] [Related]
22. Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma.
Häckel C; Czerniak B; Ayala AG; Radig K; Roessner A
Cancer; 1997 Jan; 79(1):53-8. PubMed ID: 8988726
[TBL] [Abstract][Full Text] [Related]
23. Endothelial regulation of eNOS, PAI-1 and t-PA by testosterone and dihydrotestosterone in vitro and in vivo.
Goglia L; Tosi V; Sanchez AM; Flamini MI; Fu XD; Zullino S; Genazzani AR; Simoncini T
Mol Hum Reprod; 2010 Oct; 16(10):761-9. PubMed ID: 20547636
[TBL] [Abstract][Full Text] [Related]
24. The fibrinolytic system in neoplasia.
Bell WR
Semin Thromb Hemost; 1996; 22(6):459-78. PubMed ID: 9122711
[TBL] [Abstract][Full Text] [Related]
25. Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor.
Fibbi G; Pucci M; Grappone C; Pellegrini G; Salzano R; Casini A; Milani S; Del Rosso M
Hepatology; 1999 Mar; 29(3):868-78. PubMed ID: 10051491
[TBL] [Abstract][Full Text] [Related]
26. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
27. Modulators of induction of plasminogen activator inhibitor type-1 in HepG2 cells by transforming growth factor-β.
Nakayama N; Nakamura T; Okada H; Iwaki S; Sobel BE; Fujii S
Coron Artery Dis; 2011 Nov; 22(7):468-78. PubMed ID: 21968503
[TBL] [Abstract][Full Text] [Related]
28. Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cells.
Ueshima S; Fukao H; Okada K; Matsuo O
Thromb Res; 2004; 113(1):41-9. PubMed ID: 15081564
[TBL] [Abstract][Full Text] [Related]
29. Regulation of plasminogen activators and type-1 plasminogen activator inhibitor by cyclic AMP and phorbol ester in rat astrocytes.
Tranque P; Robbins R; Naftolin F; Andrade-Gordon P
Glia; 1992; 6(3):163-71. PubMed ID: 1335967
[TBL] [Abstract][Full Text] [Related]
30. Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues.
Umeda T; Eguchi Y; Okino K; Kodama M; Hattori T
J Pathol; 1997 Dec; 183(4):388-97. PubMed ID: 9496254
[TBL] [Abstract][Full Text] [Related]
31. Antithrombotic regulation in human endothelial cells by fibrinolytic factors.
Fukao H; Matsuo O
Semin Thromb Hemost; 2000; 26(1):33-8. PubMed ID: 10805279
[TBL] [Abstract][Full Text] [Related]
32. Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis.
Guiducci S; Del Rosso A; Cinelli M; Perfetto F; Livi R; Rossi A; Gabrielli A; Giacomelli R; Iori N; Fibbi G; Del Rosso M; Cerinic MM
Arthritis Res Ther; 2005; 7(6):R1244-53. PubMed ID: 16277677
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-1beta regulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble u-PA receptor, and plasminogen activator inhibitor-1 messenger ribonucleic acid expression in cultured human endometrial stromal cells.
Chung HW; Wen Y; Ahn JJ; Moon HS; Polan ML
J Clin Endocrinol Metab; 2001 Mar; 86(3):1332-40. PubMed ID: 11238529
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor-beta1 enhances the antifibrinolytic and prothrombotic state of growing endothelial cells in a cell cycle-specific manner.
Stoldt VR; Schnorr O; Schulze-Osthoff K; Scharf RE
FASEB J; 2006 May; 20(7):965-6. PubMed ID: 16571780
[TBL] [Abstract][Full Text] [Related]
35. Regulation of plasminogen activator activity and expression by cyclic mechanical stress in rat mandibular condylar chondrocytes.
Chen W; Tang Y; Zheng M; Jiang J; Zhu G; Liang X; Li M
Mol Med Rep; 2013 Oct; 8(4):1155-62. PubMed ID: 23982192
[TBL] [Abstract][Full Text] [Related]
36. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
Sitter T; Toet K; Quax P; Kooistra T
Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
[TBL] [Abstract][Full Text] [Related]
37. Tissue-type plasminogen activator depletion affects the nasal mucosa matrix reconstruction in allergic rhinitis mice.
Hua H; Zhang R; Yu S; Wang H; Zhao Y; Yu S; Li W
Allergol Immunopathol (Madr); 2011; 39(4):206-11. PubMed ID: 21339035
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas.
Christensen L; Wiborg Simonsen AC; Heegaard CW; Moestrup SK; Andersen JA; Andreasen PA
Int J Cancer; 1996 May; 66(4):441-52. PubMed ID: 8635858
[TBL] [Abstract][Full Text] [Related]
39. Polyphyenolics increase t-PA and u-PA gene transcription in cultured human endothelial cells.
Abou-Agag LH; Aikens ML; Tabengwa EM; Benza RL; Shows SR; Grenett HE; Booyse FM
Alcohol Clin Exp Res; 2001 Feb; 25(2):155-62. PubMed ID: 11236827
[TBL] [Abstract][Full Text] [Related]
40. Characterization of human late outgrowth endothelial progenitor-derived cells under various flow conditions.
Mazzolai L; Bouzourene K; Hayoz D; Dignat-George F; Liu JW; Bounameaux H; Dunoyer-Geindre S; Kruithof EK
J Vasc Res; 2011; 48(5):443-51. PubMed ID: 21625177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
